Nancy Messonnier
#73,009
Most Influential Person Now
American medical epidemiologist at the CDC
Nancy Messonnier's AcademicInfluence.com Rankings
Nancy Messonniermedical Degrees
Medical
#1480
World Rank
#1823
Historical Rank
#387
USA Rank
Public Health
#205
World Rank
#214
Historical Rank
#58
USA Rank
Epidemiology
#863
World Rank
#899
Historical Rank
#131
USA Rank
Download Badge
Medical
Why Is Nancy Messonnier Influential?
(Suggest an Edit or Addition)According to Wikipedia, Nancy Messonnier is an American physician who served as the director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention from 2016 to 2021. She worked on the CDC's response to the COVID-19 pandemic in the United States.
Nancy Messonnier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Bacterial meningitis in the United States, 1998-2007. (2005) (641)
- Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012 (2013) (524)
- Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 (2020) (337)
- Global epidemiology of invasive meningococcal disease (2013) (324)
- Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. (2010) (298)
- Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (2018) (239)
- Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. (2012) (239)
- Waning Immunity to Pertussis Following 5 Doses of DTaP (2013) (216)
- Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. (2013) (209)
- Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States (2013) (178)
- Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults (2014) (170)
- Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. (2012) (151)
- Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. (2011) (149)
- Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2010) (137)
- Clinical Validation of Multiplex Real-Time PCR Assays for Detection of Bacterial Meningitis Pathogens (2011) (135)
- First travel-related case of 2019 novel coronavirus detected in United States : press release, Tuesday, January 21, 2020 (2020) (116)
- Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2013) (111)
- Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). (2014) (109)
- Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. (2011) (108)
- Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021 (2021) (106)
- Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. (2011) (106)
- Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. (2010) (102)
- Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial. (2008) (101)
- Pertussis control: time for something new? (2012) (94)
- sodC-Based Real-Time PCR for Detection of Neisseria meningitidis (2011) (91)
- Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic (2015) (85)
- Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. (2009) (83)
- Early Impact of the US Tdap vaccination program on pertussis trends. (2012) (82)
- Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine (2011) (81)
- Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. (2013) (69)
- Global practices of meningococcal vaccine use and impact on invasive disease (2014) (68)
- Adolescent Vaccination-Coverage Levels in the United States: 2006–2009 (2011) (67)
- Conference Report on Public Health and Clinical Guidelines for Anthrax (2008) (66)
- Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. (2008) (61)
- Haemophilus haemolyticus Isolates Causing Clinical Disease (2012) (61)
- Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (2013) (59)
- Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine (2011) (59)
- International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007☆ (2008) (55)
- Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008. (2009) (53)
- Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale (2013) (52)
- Neisseria meningitidis Serogroup W, Burkina Faso, 2012 (2014) (51)
- Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. (2009) (51)
- Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States (2015) (51)
- Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces (2012) (50)
- Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine (2017) (46)
- Use of Meningococcal Vaccines in the United States (2007) (46)
- Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali (2009) (43)
- Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt. (2013) (40)
- Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure. (2015) (38)
- Risk Factors for Meningococcal Disease in Students in Grades 9–12 (2008) (37)
- Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial. (2014) (37)
- Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt (2013) (37)
- Public Health Impact After the Introduction of PsA-TT: The First 4 Years (2015) (33)
- Whole Genome Sequencing to Investigate the Emergence of Clonal Complex 23 Neisseria meningitidis Serogroup Y Disease in the United States (2012) (33)
- Identifying Host Genetic Risk Factors in the Context of Public Health Surveillance for Invasive Pneumococcal Disease (2011) (30)
- Meningococcal carriage among Georgia and Maryland high school students. (2015) (30)
- Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women (2014) (27)
- Comparative Study of Different Sources of Pertussis Toxin (PT) as Coating Antigens in IgG Anti-PT Enzyme-Linked Immunosorbent Assays (2011) (24)
- Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011. (2012) (22)
- Genotypic Comparison of Invasive Neisseria meningitidis Serogroup Y Isolates from the United States, South Africa, and Israel, Isolated from 1999 through 2002 (2009) (21)
- Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs (2012) (19)
- Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali. (2012) (16)
- MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach. (2010) (16)
- New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent (2008) (15)
- Does Tetanus-Diphtheria-Acellular Pertussis Vaccination Interfere with Serodiagnosis of Pertussis Infection? (2012) (15)
- Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization. (2015) (15)
- Haemophilus influenzae Type b Disease and Vaccine Booster Dose Deferral, United States, 1998–2009 (2012) (14)
- Real-Time Polymerase Chain Reaction Detection of Bordetella pertussis DNA in Acellular Pertussis Vaccines (2008) (13)
- A Call to Action: Strengthening Vaccine Confidence in the United States (2020) (11)
- Title: Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US (2013) (10)
- Inching toward a serogroup B meningococcal vaccine for infants. (2012) (9)
- Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015 (2018) (9)
- Estimating the effectiveness of acellular pertussis vaccines. (2012) (9)
- Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel (2014) (8)
- Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone (2016) (8)
- Transcript for the CDC telebriefing update on COVID-19 : press briefing transcript : Wednesday, March 10, 2020 (2020) (8)
- Geotemporal Analysis of Neisseria meningitidis Clones in the United States: 2000–2005 (2013) (7)
- Integrating Host Genomics with Surveillance for Invasive Bacterial Diseases (2008) (6)
- CDC advises travelers to avoid all nonessential travel to China : media statement : Tuesday, January 28, 2020 (2020) (5)
- Haemophilus influenzae Type b Carriage among Young Children in Metropolitan Atlanta in the Context of Vaccine Shortage and Booster Dose Deferral (2011) (4)
- CDC confirms additional cases of 2019 novel coronavirus in United States : nedia statement for immediate release: Sunday, January 26, 2020 (2020) (3)
- Transcript for CDC telebriefing : CDC update on novel coronavirus : press briefing transcript : Wednesday, February 12, 2020 (2020) (2)
- Grand Rounds : The Million Hearts Initiative (2012) (2)
- COVID-19 update : Optimization strategies for healthcare personal protective equipment (PPE) (2020) (2)
- Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a 1 (2011) (1)
- Transcript for the CDC telebriefing update on COVID-19 : for immediate release : Saturday, February 29, 2020 (2020) (1)
- Country Data for Action: The MenAfriNet Experience in Strengthening Meningitis Surveillance in Africa. (2019) (1)
- CDC telebriefing : Update on COVID-19 : media advisory: Wednesday, February 12, 2020 (2020) (1)
- Transcript for CDC media telebriefing : update on COVID-19 : press briefing transcript : Friday, February 21, 2020 (2020) (1)
- CDC media telebriefing : update on COVID-19 : for immediate release : Friday, February 28, 2020 (2020) (0)
- CDC media telebriefing : update on COVID-19 : for immediate release : Tuesday Feb. 25, 2020 (2020) (0)
- Transcript of 2019 novel coronavirus response press briefing transcript : Friday, January 24, 2020 (2020) (0)
- Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt (2017) (0)
- Transcript of update on 2019 novel coronavirus response press briefing transcript : Tuesday, January 21, 2020 (2020) (0)
- and Booster Dose Deferral Atlanta in the Context of Vaccine Shortage among Young Children in Metropolitan Haemophilus influenzae Type b Carriage (2011) (0)
- Transcript for CDC media telebriefing: Update on 2019 novel coronavirus (2019-nCoV) : press briefing transcript : Friday, January 31, 2020 (2020) (0)
- Reply to Crépey and Getsios (2009) (0)
- Current Epidemiology of Meningococcal Infections (2006) (0)
- Childhood Immunization: A Key Component of Early Childhood Development. (2017) (0)
This paper list is powered by the following services:
Other Resources About Nancy Messonnier
What Schools Are Affiliated With Nancy Messonnier?
Nancy Messonnier is affiliated with the following schools:
